These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 11481275

  • 1. Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death.
    Lafuente MP, Villegas-Pérez MP, Sobrado-Calvo P, García-Avilés A, Miralles de Imperial J, Vidal-Sanz M.
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2074-84. PubMed ID: 11481275
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.
    Lafuente MP, Villegas-Pérez MP, Mayor S, Aguilera ME, Miralles de Imperial J, Vidal-Sanz M.
    Exp Eye Res; 2002 Feb; 74(2):181-9. PubMed ID: 11950228
    [Abstract] [Full Text] [Related]

  • 3. Retinal ganglion cell death induced by retinal ischemia. neuroprotective effects of two alpha-2 agonists.
    Vidal-Sanz M, Lafuente MP, Mayor S, de Imperial JM, Villegas-Pérez MP.
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S261-7; discussion S273-6. PubMed ID: 11377446
    [Abstract] [Full Text] [Related]

  • 4. Retinal ischemic injury rescued by sodium 4-phenylbutyrate in a rat model.
    Jeng YY, Lin NT, Chang PH, Huang YP, Pang VF, Liu CH, Lin CT.
    Exp Eye Res; 2007 Mar; 84(3):486-92. PubMed ID: 17178414
    [Abstract] [Full Text] [Related]

  • 5. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study.
    Sellés-Navarro I, Villegas-Pérez MP, Salvador-Silva M, Ruiz-Gómez JM, Vidal-Sanz M.
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2002-14. PubMed ID: 8814140
    [Abstract] [Full Text] [Related]

  • 6. Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death.
    Vidal-Sanz M, Lafuente MP, Mayor-Torroglosa S, Aguilera ME, Miralles de Imperial J, Villegas-Pérez MP.
    Eur J Ophthalmol; 2001 Sep; 11 Suppl 2():S36-40. PubMed ID: 11592529
    [Abstract] [Full Text] [Related]

  • 7. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
    Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, Yoles E.
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611
    [Abstract] [Full Text] [Related]

  • 8. Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine.
    Fitzgerald M, Payne SC, Bartlett CA, Evill L, Harvey AR, Dunlop SA.
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5456-62. PubMed ID: 19474405
    [Abstract] [Full Text] [Related]

  • 9. TRPC6 channel protects retinal ganglion cells in a rat model of retinal ischemia/reperfusion-induced cell death.
    Wang X, Teng L, Li A, Ge J, Laties AM, Zhang X.
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5751-8. PubMed ID: 20554625
    [Abstract] [Full Text] [Related]

  • 10. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
    Yoles E, Wheeler LA, Schwartz M.
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine.
    Avilés-Trigueros M, Mayor-Torroglosa S, García-Avilés A, Lafuente MP, Rodríguez ME, Miralles de Imperial J, Villegas-Pérez MP, Vidal-Sanz M.
    Exp Neurol; 2003 Dec; 184(2):767-77. PubMed ID: 14769369
    [Abstract] [Full Text] [Related]

  • 14. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
    Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA.
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
    [Abstract] [Full Text] [Related]

  • 15. Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model.
    Ma K, Xu L, Zhang H, Zhang S, Pu M, Jonas JB.
    Am J Ophthalmol; 2009 Feb; 147(2):326-31. PubMed ID: 18835468
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
    WoldeMussie E, Ruiz G, Wijono M, Wheeler LA.
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effects of D-allose against retinal ischemia-reperfusion injury.
    Hirooka K, Miyamoto O, Jinming P, Du Y, Itano T, Baba T, Tokuda M, Shiraga F.
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1653-7. PubMed ID: 16565406
    [Abstract] [Full Text] [Related]

  • 18. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment.
    Lönngren U, Näpänkangas U, Lafuente M, Mayor S, Lindqvist N, Vidal-Sanz M, Hallböök F.
    Brain Res Bull; 2006 Dec 11; 71(1-3):208-18. PubMed ID: 17113948
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effects of C-type natriuretic peptide on rat retinal ganglion cells.
    Ma J, Yu W, Wang Y, Cao G, Cai S, Chen X, Yan N, Yuan Y, Zeng H, Fleenor DL, Liu X, Pang IH.
    Invest Ophthalmol Vis Sci; 2010 Jul 11; 51(7):3544-53. PubMed ID: 20181846
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.
    Baptiste DC, Hartwick AT, Jollimore CA, Baldridge WH, Chauhan BC, Tremblay F, Kelly ME.
    Invest Ophthalmol Vis Sci; 2002 Aug 11; 43(8):2666-76. PubMed ID: 12147601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.